Beatrice Casadei

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 135 publications

The Prognostic Role of Interim [18F]FDG PET/CT in Diffuse Large B-Cell Lymphoma: An Updated Systematic Review and Meta-analysis.

The Prognostic Role of Interim [18F]FDG PET/CT in Diffuse Large B-Cell Lymphoma: An Updated Systematic Review and Meta-analysis.

Journal: Clinical lymphoma, myeloma & leukemia
Published: May 18, 2026

Coincidence or Connection? Revisiting the Relationship Between Mastocytosis and Lymphoma.

Coincidence or Connection? Revisiting the Relationship Between Mastocytosis and Lymphoma.

Journal: Mediterranean journal of hematology and infectious diseases
Published: April 03, 2026

Sarcoid-like Reactions in Hodgkin Lymphoma Treated with Pembrolizumab.

Sarcoid-like Reactions in Hodgkin Lymphoma Treated with Pembrolizumab.

Journal: Mediterranean journal of hematology and infectious diseases
Published: March 18, 2026

Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium.

Clinical outcomes of mature T- and NK-cell lymphomas in hepatitis B virus positive individuals: results from the PETAL Global Consortium.

Journal: Leukemia & lymphoma
Published: March 14, 2026

Efficacy of axi-cel in a patient with high-grade large B-cell lymphoma refractory to first-line therapy: importance of early identification and referral of the patient potentially eligible for CAR-T in defining the patient's outcome

Efficacy of axi-cel in a patient with high-grade large B-cell lymphoma refractory to first-line therapy: importance of early identification and referral of the patient potentially eligible for CAR-T in defining the patient's outcome

Journal: Recenti progressi in medicina
Published: February 20, 2026

Skin toxicities related to Bruton tyrosine kinase inhibitors: an updated review.

Skin toxicities related to Bruton tyrosine kinase inhibitors: an updated review.

Journal: Expert review of clinical immunology
Published: February 19, 2026

Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy.

Pirtobrutinib in relapsed or refractory mantle cell lymphoma: outcomes from the compassionate use program in Italy.

Journal: Leukemia & lymphoma
Published: January 29, 2026

Accuracy of percutaneous ultrasound-guided needle biopsy of abdominal lymph nodes for the diagnosis of malignant disease.

Accuracy of percutaneous ultrasound-guided needle biopsy of abdominal lymph nodes for the diagnosis of malignant disease.

Journal: Oncology letters
Published: January 22, 2026

Glofitamab in Heavily Pretreated Mantle Cell Lymphoma Patients: A Multicenter Real-World Case Series.

Glofitamab in Heavily Pretreated Mantle Cell Lymphoma Patients: A Multicenter Real-World Case Series.

Journal: EJHaem
Published: January 06, 2026

Risk Assessment in Large B-Cell Lymphoma Using Metabolic Tumor Volume: Real-World Data from a Multicenter Cohort of Patients Undergoing CAR T-Cell Therapy.

Risk Assessment in Large B-Cell Lymphoma Using Metabolic Tumor Volume: Real-World Data from a Multicenter Cohort of Patients Undergoing CAR T-Cell Therapy.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 05, 2026

A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.

A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.

Journal: American journal of hematology
Published: December 19, 2025

MACOP-B in Adult Langerhans Cell Histiocytosis Confirms Durable Organ Responses at an Updated Long-Term Follow-Up.

MACOP-B in Adult Langerhans Cell Histiocytosis Confirms Durable Organ Responses at an Updated Long-Term Follow-Up.

Journal: American journal of hematology
Published: December 01, 2025
Showing 1-12 of 135

Last Updated: 09/26/2026